Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Genetic Disease | Family Medicine
Sickle Cell Disease Clinical Trials
A listing of Sickle Cell Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Children's of Alabama
Evaluation of Spectra Optia RBC Exchange in Sickle Cell Patients
Mobile : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
Arkansas
Little Rock : Hematology Oncology Services of Arkansas
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
California
Los Angeles : Childrens Hospital Los Angeles
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
Oakland : Children's Hospital Oakland (CHO)
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Oakland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)
Oakland : Children's Hospital and Research Center at Oakland
Evaluation of Spectra Optia RBC Exchange in Sickle Cell Patients
Oakland : Children's Hospital Oakland
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
View More »
Orange : Children's Hospital of Orange County Sickle Cell Disease Center
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
San Diego : Rady Children's Hopsital / UC San Diego University Hospital Sickle Cell Disease Center
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Colorado
Aurora : University of Colorado at Denver
Evaluation of Spectra Optia RBC Exchange in Sickle Cell Patients
Connecticut
Stamford : Hematology Oncology, P.C.
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
District of Columbia
Washington : Howard University
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Florida
Fort Lauderdale : Broward Oncology Associates, P.A.
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Fort Myers : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
Hollywood : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
Miami : Miami Children's Hospital
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Miami : Innovative Medical Research
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
View More »
Orlando : M.D. Anderson Cancer Center Orlando
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
St. Petersburg : All Children's Hospital
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Tampa : Central Tampa Hematology and Oncology Associates
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Tampa : St. Joseph Children's Hospital
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Georgia
Augusta : Georgia Health Sciences University
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
Illinois
Chicago : University of Illinois at Chicago, Dept of Pediatrics
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Chicago : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
Oak Lawn : Abington Hematology Oncology Associates, Inc
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Kentucky
Louisville : Kosair Children's Hospital
Evaluation of Spectra Optia RBC Exchange in Sickle Cell Patients
Louisiana
Baton Rouge : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
New Orleans : LSU Department of Pediatrics Children's Hospital
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
New Orleans : Tulane University School of Medicine
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
New Orleans : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
Maryland
Baltimore : Johns Hopkins University Division of Hematology
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Baltimore : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
Baltimore : Johns Hopkins Medical
Evaluation of Spectra Optia RBC Exchange in Sickle Cell Patients
Clinton : Oncology-Hematology Associates, P.A.
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Massachusetts
Boston : Boston Comprehensive Sickle Cell Center
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Boston : Children's Hospital Boston - Harvard
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Boston : Brigham and Women's Hospital
Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease
Boston : Dana-Farber Cancer Institute
Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease
Michigan
Kalamazoo : West Michigan Cancer Center
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Missouri
Columbia : University of Missouri Child Health, Division of Pediatric Hematology/Oncology
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Kansas City : Children's Mercy Hospital
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Kansas City : Research Medical Center
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
St. Louis : Washington University
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
New Jersey
Newark : Newark Beth Israel Medical Center
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
New York
Brooklyn : New York Methodist Hospital Dept of Med/Sickle Cell Program
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Brooklyn : Interfaith Medical Center-Comprehensive Sickle Cell Program
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Brooklyn : Maimonides Medical Center
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
New Hyde Park : Cohen Children's Medical Center of NY (CCMC)
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
New York : Steven & Alexandra Cohen Children's Medical Center, New York
Pilot Study Evaluating Safety & Efficacy of a DCBT: NiCord® & UNM CBU to SCD Patients After Myeloablative Therapy
View More »
Syracuse : Center for Children's Cancer & Blood Disorders
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Valhalla : New York Medical College
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
North Carolina
Chapel Hill : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
Charlotte : Presbyterian Hospital Pediatric Sickle Cell Program
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Durham : Duke University Medical Center
Pilot Study Evaluating Safety & Efficacy of a DCBT: NiCord® & UNM CBU to SCD Patients After Myeloablative Therapy
Durham : Duke University
Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo
Ohio
Akron : Ohio Region VI Sickle Cell Program
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Cincinnati : Cincinnati Children's Medical Center
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Cincinnati : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
Cleveland : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
Dayton : The Children's Medical Center of Dayton
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Pennsylvania
Philadelphia : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
South Carolina
Charleston : Medical University of SC-Pediatric Sickle Cell Center
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Columbia : M. Francisco Gonzalez, M.D., P.A.
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Tennessee
Chattanooga : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
Memphis : Diggs-Kraus Sickle Cell Center
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Nashville : Meharry Comprehensive Sickle Cell Center
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Nashville : Sickle Cell Disease and Hemoglobinopathy Clinic Children's Hospital at Vanderbilt
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Texas
Fort Worth : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
Houston : Baylor College of Medicine-Texas Children's Hospital
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Houston : Research Site Updated
Evaluation of Purified Poloxamer 188 in Children in Crisis (EPIC)
Virginia
Newport News : Peninsula Cancer Institute
A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Washington
Wisconsin
Milwaukee : Medical College of Wisconsin
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
Milwaukee : Blood Center of Wisconsin
Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD)
France
Creteil : Réanimation Médicale, Hôpital A Chenevier-H Mondor
Effect of Inhaled Nitric Oxide in Acute Chest Syndrome (INOSTA Study)
Paris : Hoipital Robert Debre
Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children
